Lactobacillus crispatus  CTV-05  (Lactin-V,  Osel) 
is  a  live  biotherapeutic  product  that  contains  a 
naturally occurring vaginal strain of L. crispatus. Copyright Â© 2020 Massachusetts Medical Society. This cal-
culation  was  based  on  an  anticipated  dropout 
rate of 10% in the complete-case-analysis popu-
lation and an assumed cumulative percentage of 
participants  in  the  placebo  group  with  recur-
rence of bacterial vaginosis by week 12 of 30%. Secondary Outcomes
Among  the  participants  without  known  recur-
rence of bacterial vaginosis by week 12, a total 
of 13 of 106 participants (12%) in the Lactin-V 
group and 7 of 42 participants (17%) in the pla-
cebo  group  had  a  recurrence  by  week  24. Hemmerling A, Harrison W, Schroeder 
A, et al. Intermittent lactobacilli-contain-
ing  vaginal  probiotic  or  metronidazole 
use  to  prevent  bacterial  vaginosis  recur-
rence: safety and preliminary efficacy by 
microscopy and sequencing.